טוען...
Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of etanercept in patients with moderately active rheumatoid arthritis despite DMARD therapy
This study evaluated the efficacy and safety of adding etanercept to disease-modifying antirheumatic drugs (DMARDs) in patients with moderately active rheumatoid arthritis (RA). This randomized, double-blind, placebo-controlled study (ClinicalTrials.gov #NCT01313208) enrolled RA patients with Diseas...
שמור ב:
הוצא לאור ב: | Springerplus |
---|---|
Main Authors: | , , , , , , |
פורמט: | Artigo |
שפה: | Inglês |
יצא לאור: |
Springer International Publishing
2015
|
נושאים: | |
גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4359699/ https://ncbi.nlm.nih.gov/pubmed/25793152 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40064-015-0895-9 |
תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|